Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Moderna, Inc. Director's Dealing 2024

May 25, 2024

30610_dirs_2024-05-24_9a645945-5960-49c0-a625-badc954e95b9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2024-05-22

Reporting Person: AFEYAN NOUBAR (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-05-22 Common Stock S 100 $142.95 Disposed 1996831 Direct
2024-05-22 Common Stock S 200 $144.3950 Disposed 1996631 Direct
2024-05-22 Common Stock S 100 $145.03 Disposed 1996531 Direct
2024-05-22 Common Stock S 300 $147.0633 Disposed 1996231 Direct
2024-05-22 Common Stock S 600 $148.2067 Disposed 1995631 Direct
2024-05-22 Common Stock S 300 $149.4533 Disposed 1995331 Direct
2024-05-22 Common Stock S 400 $150.5950 Disposed 1994931 Direct
2024-05-22 Common Stock S 700 $151.7329 Disposed 1994231 Direct
2024-05-22 Common Stock S 800 $152.9200 Disposed 1993431 Direct
2024-05-22 Common Stock S 200 $153.8400 Disposed 1993231 Direct
2024-05-22 Common Stock S 600 $155.6600 Disposed 1992631 Direct
2024-05-22 Common Stock S 1802 $157.4117 Disposed 1990829 Direct
2024-05-22 Common Stock S 1923 $158.2529 Disposed 1988906 Direct
2024-05-22 Common Stock S 2200 $159.5683 Disposed 1986706 Direct
2024-05-22 Common Stock S 825 $160.2355 Disposed 1985881 Direct
2024-05-22 Common Stock S 1005 $162.1918 Disposed 1984876 Direct
2024-05-22 Common Stock S 2223 $163.0236 Disposed 1982653 Direct
2024-05-22 Common Stock S 625 $163.9212 Disposed 1982028 Direct
2024-05-22 Common Stock S 97 $164.67 Disposed 1981931 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 9662114 Indirect
Common Stock 3924 Indirect

Footnotes

F1: These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2023, as amended on November 7, 2023.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.95 to $144.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.53 to $147.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.91 to $148.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.18 to $151.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.42 to $152.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.44 to $153.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.62 to $154.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $155.26 to $156.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F11: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $156.73 to $157.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F12: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $157.89 to $158.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F13: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $158.90 to $159.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $159.99 to $160.89, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.55 to $162.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.58 to $163.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $163.67 to $164.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F18: 8,100,794 shares are held directly by Flagship Ventures Fund IV, L.P. ("Flagship Fund IV") and 1,561,320 shares are held directly by Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx"). Flagship Ventures Fund IV General Partner LLC ("Flagship Fund IV GP") is the general partner of each of Flagship Fund IV and Flagship Fund IV-Rx. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

F19: 3,924 shares are held directly by Flagship Pioneering, Inc. ("Flagship Pioneering"). The reporting person is the CEO and sole stockholder of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.